Literature DB >> 12195224

Multifaceted purinergic regulation of stimulus-secretion coupling in the neurohypophysis.

Jean-Denis Troadec1, Sylvie Thirion.   

Abstract

The neurohypophysis is an original model of the CNS secretory system releasing vasopressin (AVP) and oxytocin (OXT), two neuropeptides hormones synthesized by the magnocellular neurons of the hypothalamus. Specific patterns of action potentials originating from cellular bodies of magnocellular neurons control the release of AVP and OT, but intra-neurohypophysis regulations do modulate the neuropeptides release. There is now good evidence for the effects of extracellular purines in the control of neurohypophysial secretion. This paper brings together evidence for the multiple, intricate actions of purines in the extracellular space of the neurohypophysis. It covers four main points. First, the activity-dependent release of endogenous ATP in the neurohypophysis. Second, the action of ATP on both neuronal and non-neuronal compartments of the neural lobe. Third, the termination of ATP positive feedback by ecto-nucleotidases. And finally the possible involvement of adenosine in the regulation of neurohypophysial secretion and glial plasticity. The data suggest that ATP and adenosine are physiological modulators of the release of neurohypophysial peptides by acting directly on nerve terminals and indirectly on neurohypophysial astrocytes. Since purinergic receptors are widespread in nervous and endocrine systems, the neurohypophysis appears as an useful model for studying the role of purines in the regulation of stimulus-secretion coupling and neuron-glia interactions. The feedback mechanisms found in the neurohypophysis could be ubiquitous, occurring throughout the central nervous system and in other secretory systems.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195224

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  12 in total

Review 1.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

2.  Expression of P2Y receptors in the rat anterior pituitary.

Authors:  Qiang Yu; Wei Guo; Xianmin Song; Xiaofeng Liu; Zhenghua Xiang; Cheng He; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2011-05-13       Impact factor: 3.765

Review 3.  Purinergic receptor types in the hypothalamic-neurohypophysial system.

Authors:  José R Lemos; Edward E Custer; Sonia Ortiz-Miranda
Journal:  J Neuroendocrinol       Date:  2018-03-07       Impact factor: 3.627

Review 4.  Purinergic signaling pathways in endocrine system.

Authors:  Ivana Bjelobaba; Marija M Janjic; Stanko S Stojilkovic
Journal:  Auton Neurosci       Date:  2015-04-25       Impact factor: 3.145

5.  P2X receptor channels in endocrine glands.

Authors:  Stanko S Stojilkovic; Hana Zemkova
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2013

6.  Expression and roles of pannexins in ATP release in the pituitary gland.

Authors:  Shuo Li; Ivana Bjelobaba; Zonghe Yan; Marek Kucka; Melanija Tomic; Stanko S Stojilkovic
Journal:  Endocrinology       Date:  2011-04-05       Impact factor: 4.736

Review 7.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

8.  P2X7 receptors in neurohypophysial terminals: evidence for their role in arginine-vasopressin secretion.

Authors:  Adolfo E Cuadra; Edward E Custer; Elizabeth L Bosworth; José R Lemos
Journal:  J Cell Physiol       Date:  2014-03       Impact factor: 6.384

Review 9.  Purinergic regulation of hypothalamopituitary functions.

Authors:  Stanko S Stojilkovic
Journal:  Trends Endocrinol Metab       Date:  2009-10-01       Impact factor: 12.015

Review 10.  Signaling by purinergic receptors and channels in the pituitary gland.

Authors:  Stanko S Stojilkovic; Mu-Lan He; Taka-aki Koshimizu; Ales Balik; Hana Zemkova
Journal:  Mol Cell Endocrinol       Date:  2009-05-23       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.